Posts by: Alice Melão

News

A new formulation of CT-P13, a biosimilar of Remicade (infliximab), that is given as an under-the-skin (subcutaneous) injection, was shown to be as safe and effective in treating inflammatory bowel disease ... Read more

November 25, 2019November 25, 2019

Thetis Receives Funds From Crohn’s & Colitis Foundation to Further Develop TP-317 for IBD

News

The Crohn’s & Colitis Foundation is providing funding support to Thetis Pharmaceuticals for the continuing development of the novel oral therapy TP-317 for the treatment of inflammatory bowel disease (IBD). ... Read more

November 6, 2019November 6, 2019

European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

News

A new public-private initiative brings academic and industry researchers from 15 European countries together in a large-scale effort to understand differences and commonalities in seven immune-mediated and inflammatory diseases, including ... Read more

October 28, 2019October 28, 2019

Excessive Steroid Use in IBD Patients Could Be Avoided in More than Half of Cases, Study Reports

News

People with inflammatory bowel disease (IBD) in the U.K. are commonly treated with corticosteroids, but a portion of these patients are treated excessively with steroids — and more than half ... Read more

September 25, 2019September 25, 2019

PD-L2 a Potential Target to Prevent Inflammation in Crohn’s Disease, Study Reveals

News

Inhibition of the signals triggered by a molecule called PD-L2 may prevent activation of autoimmunity in the gut and the progression of Crohn’s disease, a preliminary study suggests. “This study ... Read more

March 29, 2019March 29, 2019

Young UMass Amherst Scientist Honored for Contributions to IBD, Colon Cancer Research

News

Food scientist Guodong Zhang, PhD, at the University of Massachusetts Amherst, has been granted the 2019 AOCS Young Scientist Research Award for his research on risk factors that contribute to ... Read more

February 13, 2019February 13, 2019

BBT-401 Shows Potential for Treatment of Ulcerative Colitis, Early Trials Reveal

News

The investigational therapy BBT-401 effectively prevented ulcerative colitis symptoms in mice and rat models of the disease, and was shown to be safe and well-tolerated in healthy volunteers in a Phase 1 ... Read more

February 4, 2019February 4, 2019

Monofer Cuts Frequency, Cost of Iron Infusions for Danish IDA Patients, Study Says

News

Use of Monofer (iron isomaltoside) instead of Ferinject (ferric carboxymaltose, also known as Injectafer in the U.S.) reduces the number of iron infusions required by people with inflammatory bowel disease ... Read more

October 10, 2018October 10, 2018

Regen Ready to Launch Preclinical Studies on Lead Candidate RG-NAH005 as IBD Treatment

News

Regen BioPharma, in collaboration with Zander Therapeutics, is preparing to launch preclinical studies on its lead candidate RG-NAH005 for inflammatory bowel disease (IBD), the company announced in a press release. ... Read more

September 21, 2018September 21, 2018

Compound Derived from American Ginseng Improved Colitis Symptoms in Mouse Study

News

Compound K, a byproduct of American ginseng, was seen to reduce bowel inflammation and abdominal pain in a recent study with mice. Ginseng root has been used as a food additive ... Read more